FY2024 (April 1, 2023 - March 31, 2024)

(Millions of Yen)

Takara Holdings

Inc.

(Consolidated)

y-o-

y(%)

Takara

Shuzo

y-o-

y(%)

Takara

Shuzo

International

Group

y-o-

y(%)

Takara

Bio

Group

y-o-

y(%)

Sales to customer

339,372

96.8%

123,786

100.7%

160,427

116.7%

43,505

55.7%

Cost of sales

225,438

97.7%

92,057

98.3%

108,711

114.3%

16,597

49.7%

Gross profit

113,933

95.0%

31,728

108.4%

51,715

122.0%

26,908

60.1%

SG&A expenses

91,691

111.8%

26,225

107.5%

39,423

124.9%

23,905

98.7%

Operating income

22,242

58.6%

5,503

112.5%

12,291

113.6%

3,003

14.6%

Non-operating

income

2,161

128.8%

388

71.3%

483

153.0%

513

141.5%

Non-operating

expenses

1,066

116.2%

256

45.1%

715

421.9%

111

50.3%

Ordinary income

23,336

60.3%

5,635

115.8%

12,059

110.0%

3,405

16.5%

Extraordinary gain

4,034

240.0%

23

36.7%

42

498.1%

3

0.4%

Extraordinary loss

1,132

162.9%

510

217.3%

65

96.1%

554

142.7%

Income before

income taxes and

minority interests

26,238

66.1%

5,148

109.6%

12,036

110.3%

2,853

13.4%

Net income

attributable to

owners of the parent

16,176

76.3%

3,554

109.8%

7,451

115.8%

1,480

9.2%

――――

――――

――――

――――

――――

――――

――――

――――

――――

Research and

development

expenses

8,725

97.5%

391

106.4%

0

-

8,324

97.1%

Capital

expenditures

21,915

154.7%

4,108

148.6%

6,624

140.8%

10,960

168.2%

Depreciation

9,999

109.7%

2,586

104.8%

2,618

128.2%

4,279

105.7%

Amortization of

goodwill

1179

118.1%

0

-

539

135.1%

640

106.9%